How big pharma can be convinced to share intellectual property

Greg Perry discusses intellectual property and its implications on global health.

How do you convince pharmaceutical companies to share their intellectual property so that access to affordable health care can be improved in the developing world?

It’s a question that Greg Perry, executive director of Medicines Patent Pool, hears often when talking with potential investors and partners of the United Nations-backed initiative.

Perry spoke with Devex Impact Editor Adva Saldinger on the sidelines of the International Federation of Pharmaceutical Manufacturers & Associations’ recent 27th annual meeting in New York.

Click on the above video to find out more, and hear Perry’s take on how to overcome the challenges that arise with tiered royalties and pricing models.

Want to learn more? Check out the Healthy Means campaign site and tweet us using #HealthyMeans.

Healthy Means is an online conversation hosted by Devex in partnership with Concern Worldwide, Gavi, GlaxoSmithKline, International Federation of Pharmaceutical Manufacturers & Associations, International Federation of Red Cross and Red Crescent Societies, Johnson & Johnson and the United Nations Population Fund to showcase new ideas and ways we can work together to expand health care and live better lives.

You have 2 free articles left
Log in or sign-up to unlock all of the free news on Devex.

About the author

  • Carlos stamaria 400x400 v2

    Carlos Santamaria

    As associate editor for breaking news, Carlos Santamaria supervises Devex's Manila-based news team and the creation of our daily newsletter. Carlos joined Devex after a decade working for international wire services Reuters, AP, Xinhua, EFE and Philippine social news network Rappler in Madrid, Beijing, Manila, New York and Bangkok. During that time, he also covered natural disasters on the ground in Myanmar and Japan.

Join the Discussion